JP2018500387A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018500387A5 JP2018500387A5 JP2017545516A JP2017545516A JP2018500387A5 JP 2018500387 A5 JP2018500387 A5 JP 2018500387A5 JP 2017545516 A JP2017545516 A JP 2017545516A JP 2017545516 A JP2017545516 A JP 2017545516A JP 2018500387 A5 JP2018500387 A5 JP 2018500387A5
- Authority
- JP
- Japan
- Prior art keywords
- efflux pump
- pharmaceutical composition
- pump inhibitor
- compound
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 11
- 239000003112 inhibitor Substances 0.000 claims 10
- 229960000581 salicylamide Drugs 0.000 claims 9
- 239000000203 mixture Substances 0.000 claims 8
- 108010071640 phenylalanine arginine beta-naphthylamide Proteins 0.000 claims 8
- -1 salicylamide compound Chemical class 0.000 claims 8
- BIKSKRPHKQWJCW-UHFFFAOYSA-N 3,4-dibromopyrrole-2,5-dione Chemical compound BrC1=C(Br)C(=O)NC1=O BIKSKRPHKQWJCW-UHFFFAOYSA-N 0.000 claims 4
- 241000894006 Bacteria Species 0.000 claims 4
- 208000035143 Bacterial infection Diseases 0.000 claims 4
- ZNHUFUZDUQRKBB-VXKWHMMOSA-N MC-207,110 Chemical group C([C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NC=1C=C2C=CC=CC2=CC=1)C1=CC=CC=C1 ZNHUFUZDUQRKBB-VXKWHMMOSA-N 0.000 claims 4
- 208000022362 bacterial infectious disease Diseases 0.000 claims 4
- 230000001580 bacterial effect Effects 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- YQNQNVDNTFHQSW-UHFFFAOYSA-N acetic acid [2-[[(5-nitro-2-thiazolyl)amino]-oxomethyl]phenyl] ester Chemical compound CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C([N+]([O-])=O)S1 YQNQNVDNTFHQSW-UHFFFAOYSA-N 0.000 claims 2
- 230000032770 biofilm formation Effects 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- RJMUSRYZPJIFPJ-UHFFFAOYSA-N niclosamide Chemical compound OC1=CC=C(Cl)C=C1C(=O)NC1=CC=C([N+]([O-])=O)C=C1Cl RJMUSRYZPJIFPJ-UHFFFAOYSA-N 0.000 claims 2
- 229960001920 niclosamide Drugs 0.000 claims 2
- 229960002480 nitazoxanide Drugs 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 241000589291 Acinetobacter Species 0.000 claims 1
- 241001453380 Burkholderia Species 0.000 claims 1
- 241000588722 Escherichia Species 0.000 claims 1
- 241000588748 Klebsiella Species 0.000 claims 1
- 241000588653 Neisseria Species 0.000 claims 1
- 241000589516 Pseudomonas Species 0.000 claims 1
- SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical compound NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 claims 1
- 241000607142 Salmonella Species 0.000 claims 1
- 241000607768 Shigella Species 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 230000002195 synergetic effect Effects 0.000 claims 1
- 239000011885 synergistic combination Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ702001 | 2014-11-17 | ||
| NZ70200114 | 2014-11-17 | ||
| PCT/NZ2015/050192 WO2016080846A1 (en) | 2014-11-17 | 2015-11-17 | Antibacterial compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018500387A JP2018500387A (ja) | 2018-01-11 |
| JP2018500387A5 true JP2018500387A5 (enExample) | 2018-12-27 |
Family
ID=56014262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017545516A Pending JP2018500387A (ja) | 2014-11-17 | 2015-11-17 | 抗菌化合物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20190328687A1 (enExample) |
| EP (1) | EP3220919A4 (enExample) |
| JP (1) | JP2018500387A (enExample) |
| CN (1) | CN107635563A (enExample) |
| WO (1) | WO2016080846A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX385843B (es) | 2014-09-12 | 2025-03-18 | Antibiotx Aps | Uso antibacteriano de salicilanilidas halogenadas. |
| GB201509326D0 (en) | 2015-05-29 | 2015-07-15 | Antibio Tx Aps | Novel use |
| GB201604484D0 (en) | 2016-03-16 | 2016-04-27 | Antibiotx Aps And Københavns Uni University Of Copenhagen | Topical antibacterial compositions |
| GB201805453D0 (en) * | 2018-04-03 | 2018-05-16 | Antibiotx As | Novel use |
| US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
| CN108998499A (zh) * | 2018-06-05 | 2018-12-14 | 上海海洋大学 | 一种快速测定生物被膜中大肠杆菌对抗生素耐药性的方法 |
| US11419834B2 (en) | 2019-02-25 | 2022-08-23 | Rhode Island Hospital | Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide |
| WO2020176067A1 (en) | 2019-02-25 | 2020-09-03 | Rhode Island Hospital | Methods for treating diseases or infections caused by or associated with h. pylori using a halogenated salicylanilide |
| US12514843B2 (en) * | 2019-06-19 | 2026-01-06 | QBiotics Pty Ltd | Biofilm disruption |
| CN112716944A (zh) * | 2021-02-25 | 2021-04-30 | 成都大学 | 硝基咪唑类化合物在制备抑制细菌群体感应的药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1328507B1 (en) * | 2000-10-02 | 2007-03-14 | The Research Foundation Of State University of New York | Naphthylsalicylanilides as antimicrobial and antiinflammatory agents |
| US7994225B2 (en) * | 2004-03-17 | 2011-08-09 | Rempex Pharmaceuticals, Inc. | Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections |
| US7879795B2 (en) * | 2004-05-21 | 2011-02-01 | Mpex Pharmaceuticals, Inc. | Enhancement of tigecycline potency using efflux pump inhibitors |
| EP2877159B8 (en) * | 2012-07-27 | 2018-02-14 | Izumi Technology, LLC. | Efflux inhibitor compositions and methods of treatment using the same |
-
2015
- 2015-11-17 JP JP2017545516A patent/JP2018500387A/ja active Pending
- 2015-11-17 US US15/527,267 patent/US20190328687A1/en not_active Abandoned
- 2015-11-17 EP EP15860471.0A patent/EP3220919A4/en not_active Withdrawn
- 2015-11-17 CN CN201580073500.0A patent/CN107635563A/zh active Pending
- 2015-11-17 WO PCT/NZ2015/050192 patent/WO2016080846A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018500387A5 (enExample) | ||
| El-Feky et al. | Effect of ciprofloxacin and N-acetylcysteine on bacterial adherence and biofilm formation on ureteral stent surfaces | |
| Khalaf et al. | Antibacterial, anti-biofilm activity of some non-steroidal anti-inflammatory drugs and N-acetyl cysteine against some biofilm producing uropathogens | |
| AU2017201670B2 (en) | A composition comprising an antibiotic and a dispersant or an anti-adhesive agent | |
| DOP2020000058A (es) | Compuestos monobactámicos cromanos para el tratamiento de infecciones bacterianas | |
| JP2007500697A5 (enExample) | ||
| JP2017510580A5 (enExample) | ||
| PH12019500360A1 (en) | Antibiotic compounds | |
| BRPI1011277B8 (pt) | produto de bacteriocina lactobacillus pentosus, alimento e composições farmacêuticas contendo o mesmo e uso do mesmo | |
| EA201390626A1 (ru) | Производные гидроксамовой кислоты и применение указанных производных в лечении бактериальных инфекций | |
| JP2013542992A5 (enExample) | ||
| MX336260B (es) | Composiciones para el tratamiento de infecciones de pulmon, formuladas para ser administrables mediante aerolizacion, y que incluyen tobramicina. | |
| EP4606375A3 (en) | Antibacterial compounds | |
| ATE528311T1 (de) | Glycomimetische inhibitoren des pa-il-lectins, pa-iil-lectins oder beider lectine aus pseudomonas | |
| FI3273968T3 (fi) | Minosykliiniyhdisteitä biopuolustukseen | |
| Naseef Pathoor et al. | Understanding the biofilm development of Acinetobacter baumannii and novel strategies to combat infection | |
| RU2017112303A (ru) | Способ применения комбинации нового производного гидроксамовой кислоты и антибактериального вещества | |
| Biswas et al. | Current strategies for combating Biofilm-Forming pathogens in clinical Healthcare-Associated infections | |
| BR112019024549A2 (pt) | compostos derivados de glicopeptídeo e usos dos mesmos | |
| BR112021018815A2 (pt) | Gepotidacina para uso no tratamento de infecções bacterianas do trato urinário | |
| JP2024009968A5 (enExample) | ||
| MX2024003859A (es) | Inhibidores de lpxc y usos de estos. | |
| WO2008028805A3 (de) | Verwendung einer pharmazeutischen zusammensetzung enthaltend ein anticholinergikum zur abtötung von mikroorganismen und zur behandlung von atemwegsinfektionen | |
| JP2014509656A5 (enExample) | ||
| AR110913A1 (es) | Compuesto aminoglucósido y su uso para prevenir o tratar enfermedades infecciosas |